gvtcx

PROVISION OF TUMOUR PROFILING TEST

NHS South West - Acutes Published 26 Apr 2022 Find a Tender

key details

Statuscomplete
Category (CPV) 33124130
RegionSouth West
Procedurelimited
OCIDocds-h6vhtk-0330a5

Award

SupplierValueDateStatus
EXACT SCIENCES UK LTD · · active

description

Nice guidelines recommend Endopredict, Oncotype DX or Prosigna Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Of these 3 tests it has been confirmed that Oncotype DX is the only one available under the framework, Contract Ref. Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services (2019/S 212-519575). A direct award has been made to Exact Sciences for Oncotype DX for the following reason: Specialist expertise is required and only available from one source.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
26 Apr 2022 Contract award notice (F03) Earlier regulations 010759-2022

more from NHS South West - Acutes

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.